Cargando…

Broad-Spectrum Antiviral Therapeutics

Currently there are relatively few antiviral therapeutics, and most which do exist are highly pathogen-specific or have other disadvantages. We have developed a new broad-spectrum antiviral approach, dubbed Double-stranded RNA (dsRNA) Activated Caspase Oligomerizer (DRACO) that selectively induces a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rider, Todd H., Zook, Christina E., Boettcher, Tara L., Wick, Scott T., Pancoast, Jennifer S., Zusman, Benjamin D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3144912/ https://www.ncbi.nlm.nih.gov/pubmed/21818340 http://dx.doi.org/10.1371/journal.pone.0022572

Ejemplares similares

dsRNA as broad-spectrum antiviral therapeutics
por: Xu, Congfei
Publicado: (2022)

Broad-Spectrum Antivirals and Antiviral Drug Combinations
por: Oksenych, Valentyn, et al.
Publicado: (2022)

Broad-spectrum antiviral agents
por: Zhu, Jun-Da, et al.
Publicado: (2015)

Broad-Spectrum Antivirals and Antiviral Combinations: An Editorial Update
por: Kainov, Denis, et al.
Publicado: (2022)

Modified cyclodextrins as broad-spectrum antivirals
por: Jones, Samuel T., et al.
Publicado: (2020)

Enhancing the Antiviral Potency of Nucleobases for Potential Broad-Spectrum Antiviral Therapies
por: Soto-Acosta, Ruben, et al.
Publicado: (2021)

Broad spectrum antiviral nucleosides—Our best hope for the future
por: Seley-Radtke, Katherine L., et al.
Publicado: (2021)

Broad-spectrum antivirals against viral fusion
por: Vigant, Frederic, et al.
Publicado: (2015)

Arbidol as a broad-spectrum antiviral: An update
por: Blaising, Julie, et al.
Publicado: (2014)

Broad-Spectrum Antiviral Strategies and Nucleoside Analogues
por: Geraghty, Robert J., et al.
Publicado: (2021)

The Broad-Spectrum Antiviral Protein ZAP Restricts Human Retrotransposition
por: Goodier, John L., et al.
Publicado: (2015)

Broad-Spectrum Extracellular Antiviral Properties of Cucurbit[n]urils
por: Jones, Luke M., et al.
Publicado: (2022)

The broad-spectrum antiviral functions of IFIT and IFITM proteins
por: Diamond, Michael S., et al.
Publicado: (2012)

Drug repurposing for new, efficient, broad spectrum antivirals
por: García-Serradilla, Moisés, et al.
Publicado: (2019)

Tilorone, a Broad-Spectrum Antiviral for Emerging Viruses
por: Ekins, Sean, et al.
Publicado: (2020)

Conserved coronavirus proteins as targets of broad-spectrum antivirals
por: Melo-Filho, Cleber C., et al.
Publicado: (2022)

Broad-Spectrum Antivirals Derived from Natural Products
por: Tian, Wen-Jun, et al.
Publicado: (2023)

Near-Infrared Dyes: Towards Broad-Spectrum Antivirals
por: Mariewskaya, Kseniya A., et al.
Publicado: (2022)

Preparing for the next viral threat with broad-spectrum antivirals
por: Karim, Marwah, et al.
Publicado: (2023)

Novel activities of safe-in-human broad-spectrum antiviral agents
por: Ianevski, Aleksandr, et al.
Publicado: (2018)

Broad-spectrum antiviral inhibitors targeting pandemic potential RNA viruses
por: Garcia, Gustavo, et al.
Publicado: (2023)

Broad Spectrum Antiviral Properties of Cardiotonic Steroids Used as Potential Therapeutics for Emerging Coronavirus Infections
por: Jin, Young-Hee, et al.
Publicado: (2021)

Discovery and development of safe-in-man broad-spectrum antiviral agents
por: Andersen, Petter I., et al.
Publicado: (2020)

Identification of Broad-Spectrum Antiviral Compounds by Targeting Viral Entry
por: Mazzon, Michela, et al.
Publicado: (2019)

Targeting viral entry as a strategy for broad-spectrum antivirals
por: Mazzon, Michela, et al.
Publicado: (2019)

Broad-spectrum antiviral activity of carbodine, the carbocyclic analogue of cytidine
por: De Clercq, Erik, et al.
Publicado: (1990)

Nitazoxanide: A first-in-class broad-spectrum antiviral agent
por: Rossignol, Jean-François
Publicado: (2014)

The Broad-Spectrum Antiviral Potential of the Amphibian Peptide AR-23
por: Chianese, Annalisa, et al.
Publicado: (2022)

Isatin derivatives as broad-spectrum antiviral agents: the current landscape
por: Elsaman, Tilal, et al.
Publicado: (2022)

Repurposing of cyclophilin A inhibitors as broad-spectrum antiviral agents
por: Han, Jinhe, et al.
Publicado: (2022)

Self-assembling short immunostimulatory duplex RNAs with broad-spectrum antiviral activity
por: Si, Longlong, et al.
Publicado: (2022)

An allosteric inhibitor of sirtuin 2 deacetylase activity exhibits broad-spectrum antiviral activity
por: Roche, Kathryn L., et al.
Publicado: (2023)

Discovery of Potent Broad Spectrum Antivirals Derived from Marine Actinobacteria
por: Raveh, Avi, et al.
Publicado: (2013)

Self-assembling short immunostimulatory duplex RNAs with broad spectrum antiviral activity
por: Si, Longlong, et al.
Publicado: (2021)

Novel Antifungal Activity of Q-Griffithsin, a Broad-Spectrum Antiviral Lectin
por: Nabeta, Henry W., et al.
Publicado: (2021)

A Mechanistic Paradigm for Broad-Spectrum Antivirals that Target Virus-Cell Fusion
por: Vigant, Frederic, et al.
Publicado: (2013)

NPP-669, a Novel Broad-Spectrum Antiviral Therapeutic with Excellent Cellular Uptake, Antiviral Potency, Oral Bioavailability, Preclinical Efficacy, and a Promising Safety Margin
por: Lipka, Elke, et al.
Publicado: (2022)

Azithromycin: The First Broad-spectrum Therapeutic
por: Firth, Anton, et al.
Publicado: (2020)

A Potent, Broad-Spectrum Antiviral Agent that Targets Viral Membranes
por: Wojcechowskyj, Jason A., et al.
Publicado: (2010)

SREBP-dependent lipidomic reprogramming as a broad-spectrum antiviral target
por: Yuan, Shuofeng, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_t9o3qsf9lvgsk44bp139srdfrn